Oramed Pharmaceuticals Inc.
US ˙ NasdaqCM ˙ US68403P2039

SecurityORMP / Oramed Pharmaceuticals Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in ORMP / Oramed Pharmaceuticals Inc.

On August 14, 2025 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Oramed Pharmaceuticals Inc. (US:ORMP) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 14, 2025 disclosing 3,310 shares of Oramed Pharmaceuticals Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (ORMP) in the form of stock options. The firm currently holds call options representing 6,500 of underlying shares valued at $18,525 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ORMP / Oramed Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-14 2025-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 0 -3,310 -100.00 0 -100.00
2025-05-14 2025-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 3,310 3,210 3,210.00 7 0.0000
2025-05-14 2024-12-31 13F/A-1 ORAMED PHARMACEUTICALS COM NEW 68403P203 100 0 0.00 0 0.0000
2025-02-14 2024-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 100 0 0 0.0000
2024-11-14 2024-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 100 -9,088 -98.91 0 -100.00 0.0000
2024-08-14 2024-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 9,188 -9,807 -51.63 24 -58.18 0.0001
2024-05-10 2024-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 18,995 8,600 82.73 55 129.17 0.0002
2024-02-14 2023-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 10,395 -100 -0.95 24 -11.11 0.0001
2023-11-09 2023-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 10,495 10,495 27 0.0001
2023-05-12 2023-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 0 -102,067 -100.00 0 -100.00
2023-02-09 2022-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 102,067 62,910 160.66 1,228 383.07 0.0029
2022-11-09 2022-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 39,157 31,131 387.88 254 586.49 0.0005
2022-08-11 2022-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 8,026 8,026 37 0.0001
2022-05-11 2022-03-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 0 -5,655 -100.00 0 -100.00
2022-02-11 2021-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 5,655 -2,819 -33.27 81 -56.45 0.0001
2021-11-12 2021-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 8,474 5,531 187.94 186 376.92 0.0002
2021-08-10 2021-06-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 2,943 2,943 39 0.0000
2021-02-10 2020-12-31 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 0 -355 -100.00 0 -100.00
2020-11-12 2020-09-30 13F ORAMED PHARMACEUTICALS COM NEW 68403P203 355 355 1 0.0000
2019-05-14 2019-03-31 13F/A-1 ORAMED PHARM COM NEW 68403P203 0 -16,900 -100.00 0 -100.00
2019-02-05 2018-12-31 13F ORAMED PHARM COM NEW 68403P203 16,900 0 0.00 51 -37.80 0.0004
2018-11-08 2018-09-30 13F ORAMED PHARM COM NEW 68403P203 16,900 16,900 0.00 82 60.78 0.0006
2018-05-16 2018-03-31 13F/A-1 ORAMED PHARM COM NEW 68403P203 0 -11,477 -100.00 0 -100.00
2018-02-09 2017-12-31 13F ORAMED PHARM COM NEW 68403P203 11,477 3,872 50.91 103 37.33 0.0007
2017-11-15 2017-09-30 13F ORAMED PHARM COM NEW 68403P203 7,605 5,605 280.25 75 368.75 0.0007
2017-08-14 2017-06-30 13F ORAMED PHARM COM NEW 68403P203 2,000 0 0.00 16 33.33 0.0002
2017-05-10 2017-03-31 13F ORAMED PHARM COM NEW 68403P203 2,000 -3,000 -60.00 12 -61.29 0.0001
2017-02-15 2016-12-31 13F ORAMED PHARM COM NEW 68403P203 5,000 5,000 150.00 31 158.33 0.0003
2016-08-12 2016-06-30 13F ORAMED PHARM COM NEW 68403P203 0 -10,030 -100.00 0 -100.00
2016-05-12 2016-03-31 13F ORAMED PHARM COM NEW 68403P203 10,030 -7,798 -43.74 67 -55.92 0.0009
2016-02-11 2015-12-31 13F ORAMED PHARM COM NEW 68403P203 17,828 17,828 77.75 152 126.87 0.0018
2015-11-06 2015-09-30 13F ORAMED PHARM COM NEW 68403P203 0 -719 -100.00 0 -100.00
2015-08-11 2015-06-30 13F ORAMED PHARM COM NEW 68403P203 719 -2,072 -74.24 4 -77.78 0.0001
2015-05-14 2015-03-31 13F ORAMED PHARM COM NEW 68403P203 2,791 1,195 74.87 18 157.14 0.0003
2015-02-11 2014-12-31 13F ORAMED PHARM COM NEW 68403P203 1,596 -2,500 -61.04 7 -78.79 0.0001
2014-10-31 2014-09-30 13F ORAMED PHARM COM NEW 68403P203 4,096 1,546 60.63 33 32.00 0.0005
2014-08-12 2014-06-30 13F ORAMED PHARM COM NEW 68403P203 2,550 -541 -17.50 25 -30.56 0.0004
2014-05-07 2014-03-31 13F ORAMED PHARM COM NEW 68403P203 3,091 3,091 36 0.0006
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ORAMED PHARMACEUTICALS COM NEW Call 6,500 -87.71 19 -87.05 n/a n/a n/a
2025-11-12 2025-09-30 13F ORAMED PHARMACEUTICALS COM NEW Call 52,900 -32.44 140 -21.02 n/a n/a n/a
2025-08-14 2025-06-30 13F ORAMED PHARMACEUTICALS COM NEW Call 78,300 19,475.00 176 n/a n/a n/a
2025-05-14 2025-03-31 13F ORAMED PHARMACEUTICALS COM NEW Call 400 -50.00 1 -100.00 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ORAMED PHARMACEUTICALS COM NEW Call 800 -82.22 2 -90.00 n/a n/a n/a
2025-02-14 2024-12-31 13F ORAMED PHARMACEUTICALS COM NEW Call 800 2 n/a n/a n/a
2024-11-14 2024-09-30 13F ORAMED PHARMACEUTICALS COM NEW Call 4,500 -71.88 11 -75.61 n/a n/a n/a
2024-08-14 2024-06-30 13F ORAMED PHARMACEUTICALS COM NEW Call 16,000 1,042.86 41 925.00 n/a n/a n/a
2024-05-10 2024-03-31 13F ORAMED PHARMACEUTICALS COM NEW Call 1,400 -91.46 4 -89.19 n/a n/a n/a
2024-02-14 2023-12-31 13F ORAMED PHARMACEUTICALS COM NEW Call 16,400 -52.05 38 -58.43 n/a n/a n/a
2023-11-09 2023-09-30 13F ORAMED PHARMACEUTICALS COM NEW Call 34,200 -62.66 89 -72.78 n/a n/a n/a
2023-08-09 2023-06-30 13F ORAMED PHARMACEUTICALS COM NEW Call 91,600 -10.46 328 46.64 n/a n/a n/a
2023-05-12 2023-03-31 13F ORAMED PHARMACEUTICALS COM NEW Call 102,300 172.07 223 -50.66 n/a n/a n/a
2023-02-09 2022-12-31 13F ORAMED PHARMACEUTICALS COM NEW Call 37,600 -77.47 452 -58.23 n/a n/a n/a
2022-11-09 2022-09-30 13F ORAMED PHARMACEUTICALS COM NEW Call 166,900 415.12 1,082 631.08 n/a n/a n/a
2022-08-11 2022-06-30 13F ORAMED PHARMACEUTICALS COM NEW Call 32,400 -35.59 148 -65.98 n/a n/a n/a
2022-05-12 2022-03-31 13F ORAMED PHARMACEUTICALS COM NEW Call 50,300 -5.09 435 -42.54 n/a n/a n/a
2022-02-11 2021-12-31 13F ORAMED PHARMACEUTICALS COM NEW Call 53,000 -42.33 757 -62.52 n/a n/a n/a
2021-11-12 2021-09-30 13F ORAMED PHARMACEUTICALS COM NEW Call 91,900 -19.10 2,020 32.89 n/a n/a n/a
2021-08-10 2021-06-30 13F ORAMED PHARMACEUTICALS COM NEW Call 113,600 -36.00 1,520 -15.70 n/a n/a n/a
2021-05-12 2021-03-31 13F ORAMED PHARMACEUTICALS COM NEW Call 177,500 226.89 1,803 683.91 n/a n/a n/a
2021-02-10 2020-12-31 13F ORAMED PHARMACEUTICALS COM NEW Call 54,300 -69.41 230 -87.24 n/a n/a n/a
2020-11-12 2020-09-30 13F ORAMED PHARM COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F ORAMED PHARM COM NEW Call 31,600 26.40 112 47.37 n/a n/a n/a
2020-05-13 2020-03-31 13F ORAMED PHARM COM NEW Call 25,000 -38.73 76 -63.81 n/a n/a n/a
2020-02-10 2019-12-31 13F ORAMED PHARM COM NEW Call 40,800 63.20 210 176.32 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ORAMED PHARM COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-05 2018-12-31 13F ORAMED PHARM COM NEW Call 36,000 108 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ORAMED PHARM COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F ORAMED PHARM COM NEW Call 500 5 n/a n/a n/a
2017-02-15 2016-12-31 13F ORAMED PHARM COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F ORAMED PHARM COM NEW Call 75,500 0.00 548 -13.02 n/a n/a n/a
2016-08-12 2016-06-30 13F ORAMED PHARM COM NEW Call 75,500 0.00 630 14.96 n/a n/a n/a
2015-11-06 2015-09-30 13F ORAMED PHARM COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-11 2015-06-30 13F ORAMED PHARM COM NEW Call 10,200 58 n/a n/a n/a
2015-02-11 2014-12-31 13F ORAMED PHARM COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-10-31 2014-09-30 13F ORAMED PHARM COM NEW Call 200 -97.70 2 -97.62 n/a n/a n/a
2014-08-12 2014-06-30 13F ORAMED PHARM COM NEW Call 8,700 -57.14 84 -64.26 n/a n/a n/a
2014-05-07 2014-03-31 13F ORAMED PHARM COM NEW Call 20,300 235 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-14 2025-06-30 13F ORAMED PHARMACEUTICALS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-14 2025-03-31 13F ORAMED PHARMACEUTICALS COM NEW Put 1,200 0.00 3 0.00 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ORAMED PHARMACEUTICALS COM NEW Put 1,200 3 n/a n/a n/a
2025-02-14 2024-12-31 13F ORAMED PHARMACEUTICALS COM NEW Put 1,200 3 n/a n/a n/a
2024-08-14 2024-06-30 13F ORAMED PHARMACEUTICALS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-10 2024-03-31 13F ORAMED PHARMACEUTICALS COM NEW Put 5,000 -73.82 15 -68.18 n/a n/a n/a
2024-02-14 2023-12-31 13F ORAMED PHARMACEUTICALS COM NEW Put 19,100 -1.04 44 -12.00 n/a n/a n/a
2023-11-09 2023-09-30 13F ORAMED PHARMACEUTICALS COM NEW Put 19,300 211.29 50 127.27 n/a n/a n/a
2023-08-09 2023-06-30 13F ORAMED PHARMACEUTICALS COM NEW Put 6,200 -44.64 22 -8.33 n/a n/a n/a
2023-05-12 2023-03-31 13F ORAMED PHARMACEUTICALS COM NEW Put 11,200 -57.41 24 -92.41 n/a n/a n/a
2023-02-09 2022-12-31 13F ORAMED PHARMACEUTICALS COM NEW Put 26,300 46.11 316 170.09 n/a n/a n/a
2022-11-09 2022-09-30 13F ORAMED PHARMACEUTICALS COM NEW Put 18,000 -4.76 117 34.48 n/a n/a n/a
2022-08-11 2022-06-30 13F ORAMED PHARMACEUTICALS COM NEW Put 18,900 60.17 87 -14.71 n/a n/a n/a
2022-05-12 2022-03-31 13F ORAMED PHARMACEUTICALS COM NEW Put 11,800 73.53 102 5.15 n/a n/a n/a
2022-02-11 2021-12-31 13F ORAMED PHARMACEUTICALS COM NEW Put 6,800 -58.79 97 -73.28 n/a n/a n/a
2021-11-12 2021-09-30 13F ORAMED PHARMACEUTICALS COM NEW Put 16,500 385.29 363 706.67 n/a n/a n/a
2021-08-10 2021-06-30 13F ORAMED PHARMACEUTICALS COM NEW Put 3,400 -50.00 45 -34.78 n/a n/a n/a
2021-05-12 2021-03-31 13F ORAMED PHARMACEUTICALS COM NEW Put 6,800 300.00 69 885.71 n/a n/a n/a
2021-02-10 2020-12-31 13F ORAMED PHARMACEUTICALS COM NEW Put 1,700 -75.00 7 -89.86 n/a n/a n/a
2018-11-08 2018-09-30 13F ORAMED PHARM COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-13 2018-06-30 13F ORAMED PHARM COM NEW Put 3,100 0.00 23 15.00 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ORAMED PHARM COM NEW Put 3,100 0.00 20 -28.57 n/a n/a n/a
2018-05-10 2018-03-31 13F ORAMED PHARM COM NEW Put 3,100 2,018 n/a n/a n/a
2018-02-09 2017-12-31 13F ORAMED PHARM COM NEW Put 3,100 0.00 28 -9.68 n/a n/a n/a
2017-11-15 2017-09-30 13F ORAMED PHARM COM NEW Put 3,100 -22.50 31 0.00 n/a n/a n/a
2017-08-14 2017-06-30 13F ORAMED PHARM COM NEW Put 4,000 0.00 31 24.00 n/a n/a n/a
2017-05-10 2017-03-31 13F ORAMED PHARM COM NEW Put 4,000 -42.86 25 -41.86 n/a n/a n/a
2017-02-15 2016-12-31 13F ORAMED PHARM COM NEW Put 7,000 0.00 43 -15.69 n/a n/a n/a
2016-11-14 2016-09-30 13F ORAMED PHARM COM NEW Put 7,000 0.00 51 18.60 n/a n/a n/a
2016-08-12 2016-06-30 13F ORAMED PHARM COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-12 2016-03-31 13F ORAMED PHARM COM NEW Put 400 -71.43 3 -75.00 n/a n/a n/a
2016-02-11 2015-12-31 13F ORAMED PHARM COM NEW Put 1,400 250.00 12 300.00 n/a n/a n/a
2015-11-06 2015-09-30 13F ORAMED PHARM COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-11 2015-06-30 13F ORAMED PHARM COM NEW Put 2,200 0.00 12 -14.29 n/a n/a n/a
2015-05-14 2015-03-31 13F ORAMED PHARM COM NEW Put 2,200 214.29 14 366.67 n/a n/a n/a
2015-02-11 2014-12-31 13F ORAMED PHARM COM NEW Put 700 -78.12 3 -88.46 n/a n/a n/a
2014-10-31 2014-09-30 13F ORAMED PHARM COM NEW Put 3,200 -40.74 26 -50.00 n/a n/a n/a
2014-08-12 2014-06-30 13F ORAMED PHARM COM NEW Put 5,400 -25.00 52 -38.10 n/a n/a n/a
2014-05-07 2014-03-31 13F ORAMED PHARM COM NEW Put 7,200 84 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.